MEMBER LOGIN: Your Email: Password: Remember Me
Forgot Your Password or would like to register?
JNJ Johnson & Johnson
As Of 4/25/2018 7:17:00 PM
Current Price$126.76
Current Rating2
Return Since 5/2015
Johnson & Johnson 37.84 %
S&P 50026.47 %
VFS Rating Analysis
Market ReturnAverage
return vs market
Related Links
Company News
Earnings Call Transcripts
Options Chain
Options Pricing History
For current estimates, historical performance information and more, Log in to your account.

Monthly Performance and Prediction History
Below is the monthly performance history for this security and the monthly change as compared to the stock market for this security. When a row is highlighted in green, it is identifying a stock that the model predict will outperform the portfolio for that month. When a row is highlighted in red, it is identifying a stock that the model predicted will underperform for the month. No highlight indicates the model is neutral on the stock. These predictions are always recorded at the beginning of the month, and table below shows the resulting return for the month.
DateVFS RatingPredictionRating PriceSubsequent
% Increase
Market %
Increase *
4-01-20182 $128.15   
3-01-20182 $129.88-1.33%-3.13%1.80%
* As measured by the performance of the S&P 500 for the month.

JNJ12Johnson & Johnson’s Revenue at $20 Billion in 1Q18 ( 11:00:00 AM
JNJ12Buy the Post-Earnings Lull from Johnson & Johnson ( 9:32:00 AM
JNJ12How Did Johnson & Johnson’s Consumer Segment Perform in 1Q18? ( 6:01:00 AM
JNJ12How Johnson & Johnson’s Medical Devices Segment Performed in 1Q18 ( 4:31:00 AM
JNJ12Johnson & Johnson to Participate in the 2018 Deutsche Bank 43rd Annual Health Care Conference ( 1:01:00 PM
JNJ12How Johnson & Johnson’s Pharmaceutical Segment Performed in 1Q18 ( 7:32:00 AM
JNJ12Analyzing Johnson & Johnson’s Segment-Wise Performance in 1Q18 ( 6:02:00 AM
JNJ, MDT12Johnson & Johnson’s Revenues Continued to Rise in 1Q18 ( 1:49:00 PM
JNJ12J&J, Novartis' Q1 Earnings Impress: Will Others Follow Suit? ( 7:11:00 AM
JNJ12Johnson & Johnson Stock Dips Despite Q1 Earnings Beat ( 9:43:00 AM
JNJ12Johnson & Johnson (JNJ) Q1 2018 Earnings Conference Call Transcript ( 8:35:00 AM
JNJ12Upcoming Earnings: Johnson & Johnson And IBM Are Scheduled To Report This Week ( 10:10:00 AM
JNJ12Johnson & Johnson’s Revenue Estimates for 1Q18 ( 5:07:00 AM
JNJ12Analysts’ Recommendations for Johnson & Johnson on April 16 ( 5:07:00 AM
JNJ12With A -92.14% Earnings Drop, Did Johnson & Johnson (NYSE:JNJ) Really Underperform? ( 7:16:00 AM
JNJ12A Look at Johnson & Johnson’s Darzalex ( 10:20:00 AM
JNJ7J&J Gets Court to Throw Out $151 Million Artificial Hip Verdict ( 3:51:00 PM
JNJ7The Zacks Analyst Blog Highlights: Johnson & Johnson, Honeywell, Morgan Stanley, Novartis and eBay ( 5:25:00 AM
JNJ7Top Research Reports for Johnson & Johnson, Honeywell & Morgan Stanley ( 1:14:00 PM
JNJ7Johnson & Johnson's Top-Line Growth Isn't What It Seems ( 8:23:00 AM
JNJ7Johnson & Johnson's First-Quarter 2018 Earnings Review ( 7:50:00 AM
JNJ7Pharma Stock Roundup: NVS, JNJ Q1 Sales & Earnings Top, MRK & BMY Active at AACR ( 7:43:00 AM
JNJ7Johnson & Johnson is betting on vision care and expanding beyond contacts ( 5:00:00 AM
JNJ7Johnson & Johnson is betting on vision care and expanding beyond contacts ( 5:00:00 AM
JNJ7Healthcare ETFs in Focus After Johnson & Johnson Q1 Earnings ( 12:26:00 PM
JNJ73 Drugs That Are Moving the Needle at Johnson & Johnson ( 6:00:00 PM
JNJ7Kentucky Governor Bevin: I'm not on board with JNJ opioid... ( 10:23:00 AM
JNJ7Kentucky accuses J&J of contributing to opioid epidemic ( 8:24:00 AM
JNJ7IBM and J&J stocks cut 100 points from Dow industrials in early trading ( 8:07:00 AM
JNJ7Location revealed: Johnson & Johnson institute's new HQ to go in Lake Nona's Medical City ( 6:11:00 AM
JNJ7J&J Boosts Sales Forecast On Growing Demand For Cancer Drugs ( 1:26:00 PM
JNJ7Drug Division Drives Johnson & Johnson ( 10:08:00 AM
JNJ7Why Geron Corporation's Stock Is Heading Higher Today ( 10:07:00 AM
JNJ7Johnson & Johnson tops 1Q views on sales spike, but net dips ( 8:02:00 AM
JNJ7J&J (JNJ) Tops Q1 Earnings Estimates, Raises Sales Guidance ( 6:40:00 AM
JNJ7J&J Baby Powder litigation takes new focus with asbestos claims ( 7:33:00 AM
JNJ7What to Expect from Johnson & Johnson’s 1Q18 Earnings ( 5:06:00 AM
JNJ7Better Buy: Eli Lilly and Company vs. Johnson & Johnson ( 3:31:00 AM
JNJ73 Safe Dividend Stocks for a Chaotic Market ( 4:17:00 AM
JNJ7Is J&J's (JNJ) Pharma Segment Likely to Drive Q1 Earnings? ( 8:04:00 AM
JNJ7Chardan: Assembly Biosciences Hep B Antiviral Data 'Positive,' But Undifferentiated From Competitor Johnson & Johnson ( 7:31:00 AM
JNJ7Can Johnson & Johnson Get Its Mojo Back? ( 5:15:00 AM
JNJ7Get a look at Johnson & Johnson's HQ expansion in Lake Nona (RENDERINGS) ( 9:27:00 AM
JNJ7J&J (JNJ) to Begin Pharma Q1 Earnings: What's in Store? ( 5:17:00 AM
JNJ2Amgen’s Earnings Grow 12% Year-Over-Year in 1Q18 ( 8:27:00 AM
JNJ2Novartis Launches FocalView to Modernize Clinical Trials ( 8:27:00 AM
JNJ2How Analysts Rate Bristol-Myers Squibb in 1Q18 ( 8:15:00 AM
JNJ2What Do Analysts Predict for Bristol-Myers Squibb in 1Q18? ( 5:15:00 AM
JNJ2Biktarvy Could Be a Major Driver for Gilead Sciences in 2018 ( 12:04:00 PM
JNJ2Analysts’ Estimates for Eli Lilly & Co.’s 1Q18 Earnings ( 8:39:00 AM
JNJ2Geron Corporation: The Clock Is Ticking ( 7:00:00 AM
JNJ2Why GlaxoSmithKline’s 1Q18 Revenues Are Expected to Fall ( 6:35:00 AM
JNJ2Merck’s Relebactam Met Primary Endpoints in Phase 3 Study ( 5:17:00 AM
JNJ2British businesses embrace profits with a purpose ( 5:15:00 PM
JNJ23 Things You Should Know About Today's Top Entrepreneurs ( 12:01:00 PM
JNJ24 Blue-Chip Stocks to Buy Ahead of Eye-Popping Earnings ( 11:30:00 AM
JNJ2AbbVie And Other Great Pharma And Biotech Income Stocks ( 6:03:00 AM
JNJ2Dow 30 Stock Roundup: AmEx, Goldman, IBM, JNJ, P&G, UNH Earnings Impress ( 5:15:00 AM
JNJ2P&G, GE and IBM Need to Innovate; Has Starbucks' Stock Grown Ice Cold?--ICYMI ( 4:52:00 PM
JNJ2After the Bell: Dow Drops 38 Points Because…IBM ( 3:11:00 PM
JNJ2Kentucky Gov. Matt Bevin slams state AG's lawsuit against J&J: 'These are political moves' ( 2:10:00 PM
JNJ2Kentucky Gov. Matt Bevin slams state AG's lawsuit against J&J: 'These are political moves' ( 2:10:00 PM
JNJ2MARKETS: The real test for stocks is coming from the bond market ( 7:25:00 AM
JNJ2The resume of the future will tell employers who you are, and not just what you’ve done ( 4:00:00 AM
JNJ2Trump touts economy as stocks rally ( 4:37:00 PM
JNJ2U.S. drug agency proposes rules to rein in opioid manufacturing ( 2:01:00 PM
JNJ2What to Look for as First-Quarter Earnings Hit Around the Globe ( 2:00:00 PM
JNJ2UnitedHealth and Alphabet climb; Tesla and Comerica skid ( 1:47:00 PM
JNJ2Wall Street rises on earnings hopes, Netflix soars ( 1:44:00 PM
JNJ2Dow Jumps Over 200 Points; S&P 500 and Nasdaq Also Finish Higher ( 1:08:00 PM
JNJ2J&J raises sales forecast but keeps profit outlook unchanged; shares drop ( 10:13:00 AM
JNJ2Novartis’s 1Q18: Analysts Expect Revenue Growth ( 8:10:00 AM
JNJ2J&J Lives Up to Its Valuation -- For Now ( 7:45:00 AM
JNJ2New Construction Data, Q1 Earnings In Focus ( 7:39:00 AM
JNJ2Tax Day Not So Taxing (for Corporations, Housing) ( 7:25:00 AM
JNJ2Fed speakers and earnings from Goldman Sachs and others could influence Tuesday's market ( 4:35:00 PM
JNJ2Pa., N.J. health systems and universities form multistate clinical trials consortium ( 1:01:00 PM
JNJ2Upadacitinib Could Drive AbbVie’s Long-Term Growth ( 11:50:00 AM
JNJ2Is bluebird bio, Inc. a Buy on the Dip? ( 10:17:00 AM
JNJ23 Things to Watch in the Stock Market This Week ( 7:05:00 AM
JNJ23 Top Dividend Stocks to Buy in April ( 11:16:00 AM
JNJ2Local experts talks artificial intelligence on the First Coast ( 10:56:00 AM
JNJ210 Best Stocks to Buy and Hold Forever ( 10:31:00 AM
JNJ2Here's Why Geron Stock Surged More Than 90% in 6 Months ( 8:13:00 AM
JNJ2Why Geron Corporation Stock Popped 84% in March ( 4:48:00 AM
JNJ2U.S. Senator Cory Booker Criticizes Pharma Companies in New Tax Report ( 2:51:00 PM
JNJ2Top ETF Picks for Your IRA ( 10:58:00 AM
JNJ2Why Geron Corporation Stock Is on the Rise Today ( 9:30:00 AM
JNJ2Ad Prices On Fox's 'The Ingraham Angle' Fall In The Wake Of Advertiser Boycott ( 2:19:00 AM
JNJ0[$$] Johnson & Johnson Raises Sales Outlook ( 9:17:00 PM
JNJ-6[$$] Square, eBay, and the Future of Money ( 9:01:00 PM
JNJ-6[$$] US bank earnings, World Bank-IMF spring meetings ( 7:21:00 PM

WEBSITE DISCLAIMER:  Puget Investors and Vertical Financial Systems, Inc are not registered investment advisers, broker/dealers, or research analysts/organizations. The content on this website is issued solely for information purposes and should not to be construed as an offer to buy, sell, or trade in any way, any security mentioned herein.

All information presented on this website is believed to be reliable and written in good faith, but no representation or warranty, expressed or implied is made as to their accuracy, completeness or correctness. You are responsible for doing your own research before investing in any securities mentioned herein. Readers are urged to consult with their own independent financial advisors with respect to any investment. Neither Vertical Financial Systems, Inc, nor its officers or employees accept any liability whatsoever for any direct or consequential loss arising from any use of information on this website.

Past performance is not a guarantee of future performance or accuracy. Rating calculations and methodology may change at any time, and we reserve the right to make changes which may impact the accuracy of the model without prior notice to anybody.

Be advised that employees and officers of Vertical Financial Systems, Inc and may hold positions in the securities mentioned in this website.
Website Operated by Vertical Financial Systems, Inc